CVS Health (CVS) 10-K Summary — Year Ended Dec 31, 2024
CVS Health Corporation filed its annual report for the fiscal year ended December 31, 2024. The filing describes the company as a leading health solutions company with integrated operations across retail pharmacy, pharmacy benefits management, and health insurance.
Key takeaway
Year ended Dec 31, 2024 · FY2025 10-K
CVS Health Corporation filed its annual report for the fiscal year ended December 31, 2024. The filing describes the company as a leading health solutions company with integrated operations across retail pharmacy, pharmacy benefits management, and health insurance.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$372.8B
Revenue reported for the fiscal year.
Operating income
$8.5B
Income from operations reported for the year.
Net income
$4.6B
Net income reported for the year.
Operating cash flow
$9.1B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $292.1B | n/a |
| Dec 31, 2022 | $322.5B | +10.4% |
| Dec 31, 2023 | $357.8B | +10.9% |
| Dec 31, 2024 | $372.8B | +4.2% |
Business overview
CVS Health operates four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. The company has more than nine thousand retail locations, over one thousand walk-in and primary care clinics, a leading pharmacy benefits manager with about ninety million plan members, and a senior pharmacy care business serving over eight hundred thousand patients annually. Its strategy focuses on building a personalized, technology-driven care delivery system to lower costs and improve health outcomes.
Financial performance
Revenue increased in the most recent fiscal year compared to the prior year. The company reported operating income, net income, and operating cash flow, all of which were positive.
Material risks
The filing includes a section on risk factors, but specific details are not excerpted in the provided context. Therefore, no specific material risks can be identified from the supplied data. Readers should refer to the full filing for a complete list of risks.
Liquidity and capital
The filing discusses liquidity and capital resources in the Management's Discussion and Analysis. However, specific capital allocation themes are not detailed in the provided excerpt.
What to watch
Readers should monitor the company's progress in expanding its personalized, technology-driven care delivery and health services, as emphasized in its business strategy.